nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR6—Alzheimer's disease	0.224	0.514	CbGaD
Asenapine—SLC6A4—Alzheimer's disease	0.0857	0.197	CbGaD
Asenapine—HTR2A—Donepezil—Alzheimer's disease	0.0815	0.296	CbGbCtD
Asenapine—HTR2A—Alzheimer's disease	0.0659	0.151	CbGaD
Asenapine—DRD2—Memantine—Alzheimer's disease	0.0651	0.237	CbGbCtD
Asenapine—CYP2D6—Alzheimer's disease	0.0602	0.138	CbGaD
Asenapine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0339	0.123	CbGbCtD
Asenapine—CYP2D6—Donepezil—Alzheimer's disease	0.0271	0.0986	CbGbCtD
Asenapine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0216	0.0784	CbGbCtD
Asenapine—CYP2D6—Galantamine—Alzheimer's disease	0.0175	0.0635	CbGbCtD
Asenapine—CYP3A4—Donepezil—Alzheimer's disease	0.0172	0.0627	CbGbCtD
Asenapine—CYP3A4—Galantamine—Alzheimer's disease	0.0111	0.0404	CbGbCtD
Asenapine—HTR2C—choroid plexus—Alzheimer's disease	0.006	0.0843	CbGeAlD
Asenapine—DRD3—telencephalic ventricle—Alzheimer's disease	0.00316	0.0444	CbGeAlD
Asenapine—HTR2A—choroid plexus—Alzheimer's disease	0.00301	0.0423	CbGeAlD
Asenapine—HTR7—locus ceruleus—Alzheimer's disease	0.00298	0.0419	CbGeAlD
Asenapine—HTR5A—forebrain—Alzheimer's disease	0.00237	0.0333	CbGeAlD
Asenapine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00226	0.0318	CbGeAlD
Asenapine—HTR2A—locus ceruleus—Alzheimer's disease	0.00186	0.0261	CbGeAlD
Asenapine—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00183	0.0258	CbGeAlD
Asenapine—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00178	0.0249	CbGeAlD
Asenapine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00176	0.0247	CbGeAlD
Asenapine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00152	0.0213	CbGeAlD
Asenapine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00148	0.0208	CbGeAlD
Asenapine—HTR7—telencephalic ventricle—Alzheimer's disease	0.00141	0.0199	CbGeAlD
Asenapine—Parkinsonism—Rivastigmine—Alzheimer's disease	0.00136	0.0108	CcSEcCtD
Asenapine—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.00136	0.0108	CcSEcCtD
Asenapine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00134	0.0188	CbGeAlD
Asenapine—HTR5A—nervous system—Alzheimer's disease	0.00129	0.0181	CbGeAlD
Asenapine—Suicidal ideation—Galantamine—Alzheimer's disease	0.00128	0.0102	CcSEcCtD
Asenapine—Bundle branch block—Memantine—Alzheimer's disease	0.00126	0.00998	CcSEcCtD
Asenapine—HTR5A—central nervous system—Alzheimer's disease	0.00124	0.0174	CbGeAlD
Asenapine—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00124	0.00984	CcSEcCtD
Asenapine—Bundle branch block—Rivastigmine—Alzheimer's disease	0.00123	0.00976	CcSEcCtD
Asenapine—Suicide—Memantine—Alzheimer's disease	0.00122	0.0097	CcSEcCtD
Asenapine—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00121	0.00962	CcSEcCtD
Asenapine—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.0012	0.00949	CcSEcCtD
Asenapine—Toothache—Donepezil—Alzheimer's disease	0.00115	0.00911	CcSEcCtD
Asenapine—Completed suicide—Memantine—Alzheimer's disease	0.00108	0.00856	CcSEcCtD
Asenapine—Upset stomach—Donepezil—Alzheimer's disease	0.00107	0.00846	CcSEcCtD
Asenapine—Toothache—Memantine—Alzheimer's disease	0.00104	0.00828	CcSEcCtD
Asenapine—HTR1E—forebrain—Alzheimer's disease	0.00101	0.0142	CbGeAlD
Asenapine—Electrocardiogram QT prolonged—Memantine—Alzheimer's disease	0.000987	0.00784	CcSEcCtD
Asenapine—HTR5A—brain—Alzheimer's disease	0.000984	0.0138	CbGeAlD
Asenapine—Electrocardiogram QT prolonged—Rivastigmine—Alzheimer's disease	0.000966	0.00767	CcSEcCtD
Asenapine—HTR1E—telencephalon—Alzheimer's disease	0.000931	0.0131	CbGeAlD
Asenapine—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.000927	0.00736	CcSEcCtD
Asenapine—HTR1B—blood vessel—Alzheimer's disease	0.000908	0.0128	CbGeAlD
Asenapine—Suicidal ideation—Memantine—Alzheimer's disease	0.000904	0.00718	CcSEcCtD
Asenapine—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.000884	0.00702	CcSEcCtD
Asenapine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000882	0.0124	CbGeAlD
Asenapine—HTR1D—blood vessel—Alzheimer's disease	0.000879	0.0123	CbGeAlD
Asenapine—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.000875	0.00695	CcSEcCtD
Asenapine—Blister—Rivastigmine—Alzheimer's disease	0.00086	0.00683	CcSEcCtD
Asenapine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.000842	0.00669	CcSEcCtD
Asenapine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.000823	0.00654	CcSEcCtD
Asenapine—HTR6—forebrain—Alzheimer's disease	0.000795	0.0112	CbGeAlD
Asenapine—Amoxapine—HTR6—Alzheimer's disease	0.000743	0.307	CrCbGaD
Asenapine—Dysarthria—Donepezil—Alzheimer's disease	0.000738	0.00586	CcSEcCtD
Asenapine—HTR6—telencephalon—Alzheimer's disease	0.000731	0.0103	CbGeAlD
Asenapine—HTR7—blood vessel—Alzheimer's disease	0.0007	0.00983	CbGeAlD
Asenapine—Wheezing—Donepezil—Alzheimer's disease	0.000678	0.00538	CcSEcCtD
Asenapine—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.000678	0.00538	CcSEcCtD
Asenapine—Dyskinesia—Memantine—Alzheimer's disease	0.000674	0.00536	CcSEcCtD
Asenapine—Dyskinesia—Rivastigmine—Alzheimer's disease	0.00066	0.00524	CcSEcCtD
Asenapine—Dysarthria—Rivastigmine—Alzheimer's disease	0.000655	0.00521	CcSEcCtD
Asenapine—Pain in extremity—Galantamine—Alzheimer's disease	0.000654	0.00519	CcSEcCtD
Asenapine—Inflammation—Rivastigmine—Alzheimer's disease	0.000639	0.00508	CcSEcCtD
Asenapine—Pulmonary embolism—Memantine—Alzheimer's disease	0.000634	0.00503	CcSEcCtD
Asenapine—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.00062	0.00493	CcSEcCtD
Asenapine—Skin exfoliation—Memantine—Alzheimer's disease	0.000605	0.00481	CcSEcCtD
Asenapine—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000602	0.00478	CcSEcCtD
Asenapine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.000597	0.00474	CcSEcCtD
Asenapine—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.000592	0.0047	CcSEcCtD
Asenapine—DRD1—forebrain—Alzheimer's disease	0.000591	0.0083	CbGeAlD
Asenapine—Diabetes mellitus—Donepezil—Alzheimer's disease	0.000582	0.00463	CcSEcCtD
Asenapine—Loxapine—HTR6—Alzheimer's disease	0.000581	0.24	CrCbGaD
Asenapine—Mouth ulceration—Memantine—Alzheimer's disease	0.000573	0.00455	CcSEcCtD
Asenapine—Dysphagia—Galantamine—Alzheimer's disease	0.000565	0.00449	CcSEcCtD
Asenapine—Mouth ulceration—Rivastigmine—Alzheimer's disease	0.000561	0.00445	CcSEcCtD
Asenapine—HTR1E—nervous system—Alzheimer's disease	0.00055	0.00772	CbGeAlD
Asenapine—DRD1—telencephalon—Alzheimer's disease	0.000543	0.00763	CbGeAlD
Asenapine—Abdominal discomfort—Galantamine—Alzheimer's disease	0.000542	0.0043	CcSEcCtD
Asenapine—Increased appetite—Donepezil—Alzheimer's disease	0.000539	0.00428	CcSEcCtD
Asenapine—Dermatitis bullous—Donepezil—Alzheimer's disease	0.00053	0.00421	CcSEcCtD
Asenapine—HTR1E—central nervous system—Alzheimer's disease	0.000529	0.00743	CbGeAlD
Asenapine—Diabetes mellitus—Memantine—Alzheimer's disease	0.000529	0.0042	CcSEcCtD
Asenapine—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.000517	0.00411	CcSEcCtD
Asenapine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00051	0.00405	CcSEcCtD
Asenapine—Hyponatraemia—Donepezil—Alzheimer's disease	0.000509	0.00404	CcSEcCtD
Asenapine—Osteoarthritis—Donepezil—Alzheimer's disease	0.000507	0.00403	CcSEcCtD
Asenapine—Depression—Galantamine—Alzheimer's disease	0.000502	0.00399	CcSEcCtD
Asenapine—Psychotic disorder—Donepezil—Alzheimer's disease	0.000495	0.00393	CcSEcCtD
Asenapine—Increased appetite—Memantine—Alzheimer's disease	0.00049	0.00389	CcSEcCtD
Asenapine—DRD4—brain—Alzheimer's disease	0.000487	0.00684	CbGeAlD
Asenapine—Irritability—Donepezil—Alzheimer's disease	0.000484	0.00384	CcSEcCtD
Asenapine—Dermatitis bullous—Memantine—Alzheimer's disease	0.000481	0.00382	CcSEcCtD
Asenapine—Increased appetite—Rivastigmine—Alzheimer's disease	0.000479	0.00381	CcSEcCtD
Asenapine—HTR1B—forebrain—Alzheimer's disease	0.000479	0.00673	CbGeAlD
Asenapine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000476	0.00379	CcSEcCtD
Asenapine—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000471	0.00374	CcSEcCtD
Asenapine—HTR1D—forebrain—Alzheimer's disease	0.000464	0.00651	CbGeAlD
Asenapine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000463	0.00368	CcSEcCtD
Asenapine—Hyponatraemia—Memantine—Alzheimer's disease	0.000462	0.00367	CcSEcCtD
Asenapine—Osteoarthritis—Memantine—Alzheimer's disease	0.00046	0.00365	CcSEcCtD
Asenapine—Pain in extremity—Memantine—Alzheimer's disease	0.00046	0.00365	CcSEcCtD
Asenapine—HTR2C—forebrain—Alzheimer's disease	0.000459	0.00645	CbGeAlD
Asenapine—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000452	0.00359	CcSEcCtD
Asenapine—ADRB1—forebrain—Alzheimer's disease	0.000451	0.00633	CbGeAlD
Asenapine—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00045	0.00358	CcSEcCtD
Asenapine—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00045	0.00358	CcSEcCtD
Asenapine—Psychotic disorder—Memantine—Alzheimer's disease	0.000449	0.00357	CcSEcCtD
Asenapine—DRD3—nervous system—Alzheimer's disease	0.000448	0.00629	CbGeAlD
Asenapine—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000447	0.00355	CcSEcCtD
Asenapine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000446	0.00354	CcSEcCtD
Asenapine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000444	0.00353	CcSEcCtD
Asenapine—HTR1B—telencephalon—Alzheimer's disease	0.00044	0.00619	CbGeAlD
Asenapine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00044	0.00349	CcSEcCtD
Asenapine—Irritability—Memantine—Alzheimer's disease	0.000439	0.00349	CcSEcCtD
Asenapine—Dysphagia—Donepezil—Alzheimer's disease	0.000438	0.00348	CcSEcCtD
Asenapine—HTR2A—blood vessel—Alzheimer's disease	0.000437	0.00613	CbGeAlD
Asenapine—SLC6A4—forebrain—Alzheimer's disease	0.000435	0.00611	CbGeAlD
Asenapine—DRD3—central nervous system—Alzheimer's disease	0.000431	0.00606	CbGeAlD
Asenapine—HTR6—nervous system—Alzheimer's disease	0.000431	0.00606	CbGeAlD
Asenapine—HTR2B—forebrain—Alzheimer's disease	0.000431	0.00606	CbGeAlD
Asenapine—HTR1D—telencephalon—Alzheimer's disease	0.000426	0.00599	CbGeAlD
Asenapine—Eye disorder—Galantamine—Alzheimer's disease	0.000423	0.00336	CcSEcCtD
Asenapine—HTR2C—telencephalon—Alzheimer's disease	0.000422	0.00593	CbGeAlD
Asenapine—HTR1E—brain—Alzheimer's disease	0.00042	0.0059	CbGeAlD
Asenapine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00042	0.00334	CcSEcCtD
Asenapine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00042	0.00334	CcSEcCtD
Asenapine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00042	0.00333	CcSEcCtD
Asenapine—HTR6—central nervous system—Alzheimer's disease	0.000415	0.00583	CbGeAlD
Asenapine—ADRB1—telencephalon—Alzheimer's disease	0.000414	0.00582	CbGeAlD
Asenapine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000411	0.00327	CcSEcCtD
Asenapine—Angiopathy—Galantamine—Alzheimer's disease	0.00041	0.00326	CcSEcCtD
Asenapine—Immune system disorder—Galantamine—Alzheimer's disease	0.000408	0.00325	CcSEcCtD
Asenapine—Breast disorder—Rivastigmine—Alzheimer's disease	0.000407	0.00323	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000406	0.00322	CcSEcCtD
Asenapine—SLC6A4—telencephalon—Alzheimer's disease	0.0004	0.00562	CbGeAlD
Asenapine—Weight increased—Donepezil—Alzheimer's disease	0.000399	0.00317	CcSEcCtD
Asenapine—Dysphagia—Memantine—Alzheimer's disease	0.000398	0.00316	CcSEcCtD
Asenapine—HTR2B—telencephalon—Alzheimer's disease	0.000397	0.00557	CbGeAlD
Asenapine—Mental disorder—Galantamine—Alzheimer's disease	0.000396	0.00315	CcSEcCtD
Asenapine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000395	0.00314	CcSEcCtD
Asenapine—HRH2—nervous system—Alzheimer's disease	0.000394	0.00554	CbGeAlD
Asenapine—Malnutrition—Galantamine—Alzheimer's disease	0.000394	0.00313	CcSEcCtD
Asenapine—Depression—Donepezil—Alzheimer's disease	0.000389	0.00309	CcSEcCtD
Asenapine—Dysphagia—Rivastigmine—Alzheimer's disease	0.000389	0.00309	CcSEcCtD
Asenapine—HTR1A—forebrain—Alzheimer's disease	0.000386	0.00543	CbGeAlD
Asenapine—Dysgeusia—Galantamine—Alzheimer's disease	0.000386	0.00306	CcSEcCtD
Asenapine—HRH2—central nervous system—Alzheimer's disease	0.00038	0.00533	CbGeAlD
Asenapine—Muscle spasms—Galantamine—Alzheimer's disease	0.000379	0.00301	CcSEcCtD
Asenapine—Neutropenia—Memantine—Alzheimer's disease	0.000372	0.00295	CcSEcCtD
Asenapine—HTR7—forebrain—Alzheimer's disease	0.000369	0.00519	CbGeAlD
Asenapine—Tremor—Galantamine—Alzheimer's disease	0.000369	0.00293	CcSEcCtD
Asenapine—Anaemia—Galantamine—Alzheimer's disease	0.000364	0.00289	CcSEcCtD
Asenapine—Weight increased—Memantine—Alzheimer's disease	0.000362	0.00287	CcSEcCtD
Asenapine—Agitation—Galantamine—Alzheimer's disease	0.000362	0.00287	CcSEcCtD
Asenapine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000359	0.00285	CcSEcCtD
Asenapine—ADRA1A—forebrain—Alzheimer's disease	0.000356	0.005	CbGeAlD
Asenapine—HTR1A—telencephalon—Alzheimer's disease	0.000355	0.00499	CbGeAlD
Asenapine—Malaise—Galantamine—Alzheimer's disease	0.000355	0.00282	CcSEcCtD
Asenapine—Weight increased—Rivastigmine—Alzheimer's disease	0.000354	0.00281	CcSEcCtD
Asenapine—Depression—Memantine—Alzheimer's disease	0.000353	0.00281	CcSEcCtD
Asenapine—Syncope—Galantamine—Alzheimer's disease	0.000353	0.0028	CcSEcCtD
Asenapine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000351	0.00279	CcSEcCtD
Asenapine—DRD2—forebrain—Alzheimer's disease	0.000349	0.00491	CbGeAlD
Asenapine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000346	0.00275	CcSEcCtD
Asenapine—Depression—Rivastigmine—Alzheimer's disease	0.000346	0.00275	CcSEcCtD
Asenapine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000345	0.00274	CcSEcCtD
Asenapine—DRD3—brain—Alzheimer's disease	0.000343	0.00481	CbGeAlD
Asenapine—Convulsion—Galantamine—Alzheimer's disease	0.000341	0.00271	CcSEcCtD
Asenapine—Hypertension—Galantamine—Alzheimer's disease	0.00034	0.0027	CcSEcCtD
Asenapine—HTR7—telencephalon—Alzheimer's disease	0.00034	0.00477	CbGeAlD
Asenapine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000335	0.00266	CcSEcCtD
Asenapine—Arthralgia—Galantamine—Alzheimer's disease	0.000335	0.00266	CcSEcCtD
Asenapine—Anxiety—Galantamine—Alzheimer's disease	0.000334	0.00265	CcSEcCtD
Asenapine—Agranulocytosis—Memantine—Alzheimer's disease	0.000331	0.00263	CcSEcCtD
Asenapine—HTR6—brain—Alzheimer's disease	0.00033	0.00463	CbGeAlD
Asenapine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000328	0.00261	CcSEcCtD
Asenapine—Dry mouth—Galantamine—Alzheimer's disease	0.000328	0.0026	CcSEcCtD
Asenapine—ADRA1A—telencephalon—Alzheimer's disease	0.000328	0.0046	CbGeAlD
Asenapine—DRD2—telencephalon—Alzheimer's disease	0.000321	0.00451	CbGeAlD
Asenapine—DRD1—nervous system—Alzheimer's disease	0.000321	0.00451	CbGeAlD
Asenapine—Shock—Galantamine—Alzheimer's disease	0.000316	0.00251	CcSEcCtD
Asenapine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000315	0.0025	CcSEcCtD
Asenapine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000315	0.0025	CcSEcCtD
Asenapine—Tachycardia—Galantamine—Alzheimer's disease	0.000314	0.00249	CcSEcCtD
Asenapine—Oedema peripheral—Memantine—Alzheimer's disease	0.000313	0.00249	CcSEcCtD
Asenapine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000313	0.00248	CcSEcCtD
Asenapine—ADRA2C—telencephalon—Alzheimer's disease	0.000312	0.00439	CbGeAlD
Asenapine—DRD1—central nervous system—Alzheimer's disease	0.000309	0.00434	CbGeAlD
Asenapine—Mental disorder—Donepezil—Alzheimer's disease	0.000307	0.00244	CcSEcCtD
Asenapine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000307	0.00244	CcSEcCtD
Asenapine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000306	0.00243	CcSEcCtD
Asenapine—Malnutrition—Donepezil—Alzheimer's disease	0.000305	0.00242	CcSEcCtD
Asenapine—HRH2—brain—Alzheimer's disease	0.000301	0.00423	CbGeAlD
Asenapine—Hypotension—Galantamine—Alzheimer's disease	0.0003	0.00239	CcSEcCtD
Asenapine—Dysgeusia—Donepezil—Alzheimer's disease	0.000299	0.00237	CcSEcCtD
Asenapine—Eye disorder—Memantine—Alzheimer's disease	0.000297	0.00236	CcSEcCtD
Asenapine—Cardiac disorder—Memantine—Alzheimer's disease	0.000295	0.00235	CcSEcCtD
Asenapine—Muscle spasms—Donepezil—Alzheimer's disease	0.000293	0.00233	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000293	0.00233	CcSEcCtD
Asenapine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000291	0.00231	CcSEcCtD
Asenapine—Insomnia—Galantamine—Alzheimer's disease	0.000291	0.00231	CcSEcCtD
Asenapine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000289	0.0023	CcSEcCtD
Asenapine—Angiopathy—Memantine—Alzheimer's disease	0.000289	0.00229	CcSEcCtD
Asenapine—Immune system disorder—Memantine—Alzheimer's disease	0.000287	0.00228	CcSEcCtD
Asenapine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000287	0.00228	CcSEcCtD
Asenapine—Tremor—Donepezil—Alzheimer's disease	0.000286	0.00227	CcSEcCtD
Asenapine—Somnolence—Galantamine—Alzheimer's disease	0.000286	0.00227	CcSEcCtD
Asenapine—Amoxapine—SLC6A4—Alzheimer's disease	0.000285	0.118	CrCbGaD
Asenapine—Dyspepsia—Galantamine—Alzheimer's disease	0.000283	0.00225	CcSEcCtD
Asenapine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000282	0.00224	CcSEcCtD
Asenapine—Anaemia—Donepezil—Alzheimer's disease	0.000282	0.00224	CcSEcCtD
Asenapine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000281	0.00223	CcSEcCtD
Asenapine—Agitation—Donepezil—Alzheimer's disease	0.00028	0.00223	CcSEcCtD
Asenapine—Mental disorder—Memantine—Alzheimer's disease	0.000279	0.00221	CcSEcCtD
Asenapine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000277	0.0022	CcSEcCtD
Asenapine—Malnutrition—Memantine—Alzheimer's disease	0.000277	0.0022	CcSEcCtD
Asenapine—Fatigue—Galantamine—Alzheimer's disease	0.000277	0.0022	CcSEcCtD
Asenapine—HRH1—forebrain—Alzheimer's disease	0.000276	0.00387	CbGeAlD
Asenapine—Malaise—Donepezil—Alzheimer's disease	0.000275	0.00219	CcSEcCtD
Asenapine—Constipation—Galantamine—Alzheimer's disease	0.000275	0.00218	CcSEcCtD
Asenapine—Syncope—Donepezil—Alzheimer's disease	0.000274	0.00217	CcSEcCtD
Asenapine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000273	0.00217	CcSEcCtD
Asenapine—Dysgeusia—Memantine—Alzheimer's disease	0.000271	0.00216	CcSEcCtD
Asenapine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000271	0.00215	CcSEcCtD
Asenapine—ADRA2A—forebrain—Alzheimer's disease	0.000271	0.00381	CbGeAlD
Asenapine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000268	0.00213	CcSEcCtD
Asenapine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000265	0.00211	CcSEcCtD
Asenapine—Convulsion—Donepezil—Alzheimer's disease	0.000264	0.0021	CcSEcCtD
Asenapine—Hypertension—Donepezil—Alzheimer's disease	0.000263	0.00209	CcSEcCtD
Asenapine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000261	0.00207	CcSEcCtD
Asenapine—HTR2A—embryo—Alzheimer's disease	0.00026	0.00366	CbGeAlD
Asenapine—HTR1B—nervous system—Alzheimer's disease	0.00026	0.00365	CbGeAlD
Asenapine—Arthralgia—Donepezil—Alzheimer's disease	0.00026	0.00206	CcSEcCtD
Asenapine—Tremor—Memantine—Alzheimer's disease	0.00026	0.00206	CcSEcCtD
Asenapine—Anxiety—Donepezil—Alzheimer's disease	0.000259	0.00206	CcSEcCtD
Asenapine—Anaemia—Memantine—Alzheimer's disease	0.000256	0.00203	CcSEcCtD
Asenapine—Agitation—Memantine—Alzheimer's disease	0.000255	0.00202	CcSEcCtD
Asenapine—Dry mouth—Donepezil—Alzheimer's disease	0.000254	0.00202	CcSEcCtD
Asenapine—Tremor—Rivastigmine—Alzheimer's disease	0.000254	0.00202	CcSEcCtD
Asenapine—HRH1—telencephalon—Alzheimer's disease	0.000254	0.00356	CbGeAlD
Asenapine—HTR1D—nervous system—Alzheimer's disease	0.000252	0.00354	CbGeAlD
Asenapine—Anaemia—Rivastigmine—Alzheimer's disease	0.00025	0.00199	CcSEcCtD
Asenapine—HTR1B—central nervous system—Alzheimer's disease	0.00025	0.00352	CbGeAlD
Asenapine—Malaise—Memantine—Alzheimer's disease	0.00025	0.00198	CcSEcCtD
Asenapine—HTR2C—nervous system—Alzheimer's disease	0.000249	0.0035	CbGeAlD
Asenapine—ADRA2A—telencephalon—Alzheimer's disease	0.000249	0.0035	CbGeAlD
Asenapine—Agitation—Rivastigmine—Alzheimer's disease	0.000249	0.00198	CcSEcCtD
Asenapine—Syncope—Memantine—Alzheimer's disease	0.000248	0.00197	CcSEcCtD
Asenapine—Leukopenia—Memantine—Alzheimer's disease	0.000248	0.00197	CcSEcCtD
Asenapine—DRD1—brain—Alzheimer's disease	0.000245	0.00345	CbGeAlD
Asenapine—Shock—Donepezil—Alzheimer's disease	0.000245	0.00195	CcSEcCtD
Asenapine—ADRB1—nervous system—Alzheimer's disease	0.000245	0.00344	CbGeAlD
Asenapine—Malaise—Rivastigmine—Alzheimer's disease	0.000244	0.00194	CcSEcCtD
Asenapine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000244	0.00194	CcSEcCtD
Asenapine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000244	0.00194	CcSEcCtD
Asenapine—Loss of consciousness—Memantine—Alzheimer's disease	0.000243	0.00193	CcSEcCtD
Asenapine—Syncope—Rivastigmine—Alzheimer's disease	0.000243	0.00193	CcSEcCtD
Asenapine—HTR1D—central nervous system—Alzheimer's disease	0.000242	0.0034	CbGeAlD
Asenapine—Convulsion—Memantine—Alzheimer's disease	0.00024	0.00191	CcSEcCtD
Asenapine—HTR2C—central nervous system—Alzheimer's disease	0.00024	0.00337	CbGeAlD
Asenapine—Hypertension—Memantine—Alzheimer's disease	0.000239	0.0019	CcSEcCtD
Asenapine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000238	0.00189	CcSEcCtD
Asenapine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000237	0.00188	CcSEcCtD
Asenapine—SLC6A4—nervous system—Alzheimer's disease	0.000236	0.00332	CbGeAlD
Asenapine—Arthralgia—Memantine—Alzheimer's disease	0.000236	0.00187	CcSEcCtD
Asenapine—ADRB1—central nervous system—Alzheimer's disease	0.000235	0.00331	CbGeAlD
Asenapine—Anxiety—Memantine—Alzheimer's disease	0.000235	0.00187	CcSEcCtD
Asenapine—Convulsion—Rivastigmine—Alzheimer's disease	0.000235	0.00187	CcSEcCtD
Asenapine—HTR2B—nervous system—Alzheimer's disease	0.000234	0.00329	CbGeAlD
Asenapine—Hypertension—Rivastigmine—Alzheimer's disease	0.000234	0.00186	CcSEcCtD
Asenapine—Hypotension—Donepezil—Alzheimer's disease	0.000233	0.00185	CcSEcCtD
Asenapine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000231	0.00183	CcSEcCtD
Asenapine—Dry mouth—Memantine—Alzheimer's disease	0.000231	0.00183	CcSEcCtD
Asenapine—Asthenia—Galantamine—Alzheimer's disease	0.000231	0.00183	CcSEcCtD
Asenapine—HTR2A—forebrain—Alzheimer's disease	0.00023	0.00324	CbGeAlD
Asenapine—Anxiety—Rivastigmine—Alzheimer's disease	0.00023	0.00183	CcSEcCtD
Asenapine—SLC6A4—central nervous system—Alzheimer's disease	0.000227	0.0032	CbGeAlD
Asenapine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000227	0.0018	CcSEcCtD
Asenapine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000226	0.00179	CcSEcCtD
Asenapine—HTR2B—central nervous system—Alzheimer's disease	0.000225	0.00317	CbGeAlD
Asenapine—Insomnia—Donepezil—Alzheimer's disease	0.000225	0.00179	CcSEcCtD
Asenapine—Shock—Memantine—Alzheimer's disease	0.000222	0.00177	CcSEcCtD
Asenapine—Loxapine—SLC6A4—Alzheimer's disease	0.000222	0.0918	CrCbGaD
Asenapine—Dyspnoea—Donepezil—Alzheimer's disease	0.000222	0.00176	CcSEcCtD
Asenapine—Nervous system disorder—Memantine—Alzheimer's disease	0.000222	0.00176	CcSEcCtD
Asenapine—Somnolence—Donepezil—Alzheimer's disease	0.000221	0.00176	CcSEcCtD
Asenapine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000221	0.00176	CcSEcCtD
Asenapine—Tachycardia—Memantine—Alzheimer's disease	0.000221	0.00175	CcSEcCtD
Asenapine—Dyspepsia—Donepezil—Alzheimer's disease	0.000219	0.00174	CcSEcCtD
Asenapine—Amoxapine—HTR2A—Alzheimer's disease	0.000219	0.0904	CrCbGaD
Asenapine—Shock—Rivastigmine—Alzheimer's disease	0.000218	0.00173	CcSEcCtD
Asenapine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000217	0.00172	CcSEcCtD
Asenapine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000217	0.00172	CcSEcCtD
Asenapine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000216	0.00171	CcSEcCtD
Asenapine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000215	0.00171	CcSEcCtD
Asenapine—Fatigue—Donepezil—Alzheimer's disease	0.000215	0.00171	CcSEcCtD
Asenapine—Constipation—Donepezil—Alzheimer's disease	0.000213	0.00169	CcSEcCtD
Asenapine—Dizziness—Galantamine—Alzheimer's disease	0.000212	0.00169	CcSEcCtD
Asenapine—HTR2A—telencephalon—Alzheimer's disease	0.000212	0.00298	CbGeAlD
Asenapine—Hypotension—Memantine—Alzheimer's disease	0.000211	0.00168	CcSEcCtD
Asenapine—CYP2D6—forebrain—Alzheimer's disease	0.00021	0.00295	CbGeAlD
Asenapine—HTR1A—nervous system—Alzheimer's disease	0.00021	0.00295	CbGeAlD
Asenapine—Hypotension—Rivastigmine—Alzheimer's disease	0.000207	0.00164	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000206	0.00164	CcSEcCtD
Asenapine—Insomnia—Memantine—Alzheimer's disease	0.000204	0.00162	CcSEcCtD
Asenapine—Vomiting—Galantamine—Alzheimer's disease	0.000204	0.00162	CcSEcCtD
Asenapine—Rash—Galantamine—Alzheimer's disease	0.000203	0.00161	CcSEcCtD
Asenapine—Dermatitis—Galantamine—Alzheimer's disease	0.000202	0.00161	CcSEcCtD
Asenapine—HTR1A—central nervous system—Alzheimer's disease	0.000202	0.00284	CbGeAlD
Asenapine—Dyspnoea—Memantine—Alzheimer's disease	0.000202	0.0016	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000202	0.0016	CcSEcCtD
Asenapine—Headache—Galantamine—Alzheimer's disease	0.000201	0.0016	CcSEcCtD
Asenapine—Somnolence—Memantine—Alzheimer's disease	0.000201	0.0016	CcSEcCtD
Asenapine—HTR7—nervous system—Alzheimer's disease	0.000201	0.00282	CbGeAlD
Asenapine—Insomnia—Rivastigmine—Alzheimer's disease	0.0002	0.00159	CcSEcCtD
Asenapine—Amoxapine—CYP2D6—Alzheimer's disease	0.0002	0.0826	CrCbGaD
Asenapine—Dyspepsia—Memantine—Alzheimer's disease	0.000199	0.00158	CcSEcCtD
Asenapine—HTR1B—brain—Alzheimer's disease	0.000199	0.00279	CbGeAlD
Asenapine—HTR1A—cerebellum—Alzheimer's disease	0.000197	0.00277	CbGeAlD
Asenapine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000197	0.00157	CcSEcCtD
Asenapine—Somnolence—Rivastigmine—Alzheimer's disease	0.000197	0.00156	CcSEcCtD
Asenapine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000195	0.00155	CcSEcCtD
Asenapine—Fatigue—Memantine—Alzheimer's disease	0.000195	0.00155	CcSEcCtD
Asenapine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000195	0.00155	CcSEcCtD
Asenapine—ADRA1A—nervous system—Alzheimer's disease	0.000193	0.00272	CbGeAlD
Asenapine—Constipation—Memantine—Alzheimer's disease	0.000193	0.00154	CcSEcCtD
Asenapine—HTR7—central nervous system—Alzheimer's disease	0.000193	0.00271	CbGeAlD
Asenapine—CYP2D6—telencephalon—Alzheimer's disease	0.000193	0.00271	CbGeAlD
Asenapine—HTR1D—brain—Alzheimer's disease	0.000192	0.0027	CbGeAlD
Asenapine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000191	0.00152	CcSEcCtD
Asenapine—Nausea—Galantamine—Alzheimer's disease	0.000191	0.00152	CcSEcCtD
Asenapine—Fatigue—Rivastigmine—Alzheimer's disease	0.000191	0.00151	CcSEcCtD
Asenapine—HTR2C—brain—Alzheimer's disease	0.000191	0.00268	CbGeAlD
Asenapine—DRD2—nervous system—Alzheimer's disease	0.00019	0.00266	CbGeAlD
Asenapine—Constipation—Rivastigmine—Alzheimer's disease	0.000189	0.0015	CcSEcCtD
Asenapine—HTR7—cerebellum—Alzheimer's disease	0.000189	0.00265	CbGeAlD
Asenapine—ADRB1—brain—Alzheimer's disease	0.000187	0.00263	CbGeAlD
Asenapine—ADRA1A—central nervous system—Alzheimer's disease	0.000186	0.00262	CbGeAlD
Asenapine—ADRA2C—nervous system—Alzheimer's disease	0.000184	0.00259	CbGeAlD
Asenapine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000183	0.00146	CcSEcCtD
Asenapine—DRD2—central nervous system—Alzheimer's disease	0.000183	0.00256	CbGeAlD
Asenapine—ADRA1A—cerebellum—Alzheimer's disease	0.000182	0.00256	CbGeAlD
Asenapine—SLC6A4—brain—Alzheimer's disease	0.000181	0.00254	CbGeAlD
Asenapine—HTR2B—brain—Alzheimer's disease	0.000179	0.00251	CbGeAlD
Asenapine—Asthenia—Donepezil—Alzheimer's disease	0.000179	0.00142	CcSEcCtD
Asenapine—DRD2—cerebellum—Alzheimer's disease	0.000178	0.00251	CbGeAlD
Asenapine—ADRA2C—central nervous system—Alzheimer's disease	0.000177	0.00249	CbGeAlD
Asenapine—ADRA2C—cerebellum—Alzheimer's disease	0.000173	0.00244	CbGeAlD
Asenapine—Loxapine—HTR2A—Alzheimer's disease	0.000171	0.0706	CrCbGaD
Asenapine—Hypersensitivity—Memantine—Alzheimer's disease	0.000167	0.00132	CcSEcCtD
Asenapine—Dizziness—Donepezil—Alzheimer's disease	0.000165	0.00131	CcSEcCtD
Asenapine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000163	0.00129	CcSEcCtD
Asenapine—Asthenia—Memantine—Alzheimer's disease	0.000162	0.00129	CcSEcCtD
Asenapine—HTR1A—brain—Alzheimer's disease	0.00016	0.00225	CbGeAlD
Asenapine—Asthenia—Rivastigmine—Alzheimer's disease	0.000159	0.00126	CcSEcCtD
Asenapine—Vomiting—Donepezil—Alzheimer's disease	0.000158	0.00126	CcSEcCtD
Asenapine—Rash—Donepezil—Alzheimer's disease	0.000157	0.00125	CcSEcCtD
Asenapine—Dermatitis—Donepezil—Alzheimer's disease	0.000157	0.00125	CcSEcCtD
Asenapine—Headache—Donepezil—Alzheimer's disease	0.000156	0.00124	CcSEcCtD
Asenapine—HTR7—brain—Alzheimer's disease	0.000153	0.00215	CbGeAlD
Asenapine—HRH1—nervous system—Alzheimer's disease	0.00015	0.0021	CbGeAlD
Asenapine—Dizziness—Memantine—Alzheimer's disease	0.00015	0.00119	CcSEcCtD
Asenapine—Nausea—Donepezil—Alzheimer's disease	0.000148	0.00118	CcSEcCtD
Asenapine—ADRA1A—brain—Alzheimer's disease	0.000148	0.00208	CbGeAlD
Asenapine—ADRA2A—nervous system—Alzheimer's disease	0.000147	0.00207	CbGeAlD
Asenapine—Dizziness—Rivastigmine—Alzheimer's disease	0.000146	0.00116	CcSEcCtD
Asenapine—DRD2—brain—Alzheimer's disease	0.000145	0.00204	CbGeAlD
Asenapine—HRH1—central nervous system—Alzheimer's disease	0.000144	0.00202	CbGeAlD
Asenapine—Vomiting—Memantine—Alzheimer's disease	0.000144	0.00114	CcSEcCtD
Asenapine—Rash—Memantine—Alzheimer's disease	0.000143	0.00113	CcSEcCtD
Asenapine—Dermatitis—Memantine—Alzheimer's disease	0.000142	0.00113	CcSEcCtD
Asenapine—Headache—Memantine—Alzheimer's disease	0.000142	0.00113	CcSEcCtD
Asenapine—ADRA2A—central nervous system—Alzheimer's disease	0.000142	0.00199	CbGeAlD
Asenapine—ADRA2C—brain—Alzheimer's disease	0.000141	0.00198	CbGeAlD
Asenapine—Vomiting—Rivastigmine—Alzheimer's disease	0.000141	0.00112	CcSEcCtD
Asenapine—Rash—Rivastigmine—Alzheimer's disease	0.000139	0.00111	CcSEcCtD
Asenapine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000139	0.00111	CcSEcCtD
Asenapine—Headache—Rivastigmine—Alzheimer's disease	0.000139	0.0011	CcSEcCtD
Asenapine—ADRA2A—cerebellum—Alzheimer's disease	0.000138	0.00194	CbGeAlD
Asenapine—Nausea—Memantine—Alzheimer's disease	0.000134	0.00107	CcSEcCtD
Asenapine—Nausea—Rivastigmine—Alzheimer's disease	0.000131	0.00104	CcSEcCtD
Asenapine—HTR2A—nervous system—Alzheimer's disease	0.000125	0.00176	CbGeAlD
Asenapine—HTR2A—central nervous system—Alzheimer's disease	0.00012	0.00169	CbGeAlD
Asenapine—HTR2A—cerebellum—Alzheimer's disease	0.000118	0.00165	CbGeAlD
Asenapine—CYP3A4—nervous system—Alzheimer's disease	0.000116	0.00163	CbGeAlD
Asenapine—HRH1—brain—Alzheimer's disease	0.000114	0.00161	CbGeAlD
Asenapine—CYP2D6—nervous system—Alzheimer's disease	0.000114	0.0016	CbGeAlD
Asenapine—ADRA2A—brain—Alzheimer's disease	0.000112	0.00158	CbGeAlD
Asenapine—CYP3A4—central nervous system—Alzheimer's disease	0.000111	0.00157	CbGeAlD
Asenapine—CYP2D6—central nervous system—Alzheimer's disease	0.00011	0.00154	CbGeAlD
Asenapine—CYP2D6—cerebellum—Alzheimer's disease	0.000107	0.00151	CbGeAlD
Asenapine—HTR2A—brain—Alzheimer's disease	9.56e-05	0.00134	CbGeAlD
Asenapine—CYP2D6—brain—Alzheimer's disease	8.71e-05	0.00122	CbGeAlD
Asenapine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.25e-06	2.5e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.23e-06	2.48e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	2.23e-06	2.48e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.23e-06	2.48e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	2.23e-06	2.48e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.22e-06	2.47e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.22e-06	2.47e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.22e-06	2.46e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.21e-06	2.46e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	2.21e-06	2.45e-05	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.21e-06	2.45e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.21e-06	2.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.2e-06	2.44e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.19e-06	2.44e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	2.19e-06	2.44e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.19e-06	2.43e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—Alzheimer's disease	2.18e-06	2.43e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.18e-06	2.43e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.18e-06	2.43e-05	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.18e-06	2.42e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.18e-06	2.42e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.17e-06	2.42e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.17e-06	2.41e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.16e-06	2.4e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-06	2.4e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	2.16e-06	2.4e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	2.15e-06	2.39e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	2.15e-06	2.39e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.15e-06	2.39e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.15e-06	2.39e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.15e-06	2.39e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	2.15e-06	2.38e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	2.14e-06	2.38e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	2.14e-06	2.38e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	2.14e-06	2.38e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	2.14e-06	2.38e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.13e-06	2.37e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.13e-06	2.36e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—Alzheimer's disease	2.13e-06	2.36e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.12e-06	2.35e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.12e-06	2.35e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.11e-06	2.35e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.11e-06	2.34e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.1e-06	2.34e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.1e-06	2.33e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.08e-06	2.32e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.08e-06	2.31e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.07e-06	2.3e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	2.06e-06	2.29e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—AKT1—Alzheimer's disease	2.02e-06	2.24e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.01e-06	2.24e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.01e-06	2.24e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.01e-06	2.24e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.01e-06	2.23e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2e-06	2.23e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2e-06	2.22e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.99e-06	2.21e-05	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.99e-06	2.21e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.98e-06	2.21e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.98e-06	2.2e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.98e-06	2.2e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.98e-06	2.2e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.97e-06	2.19e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.97e-06	2.19e-05	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.97e-06	2.19e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	1.97e-06	2.19e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.96e-06	2.18e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	1.95e-06	2.17e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.95e-06	2.17e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.95e-06	2.17e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.95e-06	2.16e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.95e-06	2.16e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—Alzheimer's disease	1.95e-06	2.16e-05	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.94e-06	2.16e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.94e-06	2.15e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	1.92e-06	2.14e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.92e-06	2.14e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.92e-06	2.14e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.91e-06	2.13e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	1.91e-06	2.13e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.91e-06	2.12e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.91e-06	2.12e-05	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.9e-06	2.11e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.89e-06	2.1e-05	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.89e-06	2.1e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.88e-06	2.09e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.87e-06	2.08e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.87e-06	2.08e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.87e-06	2.08e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.86e-06	2.07e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.86e-06	2.07e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-06	2.06e-05	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.84e-06	2.04e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.83e-06	2.04e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.83e-06	2.04e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.82e-06	2.02e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.82e-06	2.02e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.81e-06	2.01e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.81e-06	2.01e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.81e-06	2.01e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.81e-06	2.01e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.8e-06	2e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.8e-06	2e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.8e-06	2e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—Alzheimer's disease	1.79e-06	1.99e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.79e-06	1.99e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.79e-06	1.99e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	1.77e-06	1.97e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	1.76e-06	1.96e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.74e-06	1.94e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.73e-06	1.92e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.72e-06	1.92e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.72e-06	1.91e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.72e-06	1.91e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.7e-06	1.89e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-06	1.87e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.67e-06	1.86e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.67e-06	1.86e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.67e-06	1.85e-05	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.67e-06	1.85e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.65e-06	1.84e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.65e-06	1.84e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.65e-06	1.83e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.64e-06	1.82e-05	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.64e-06	1.82e-05	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.64e-06	1.82e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	1.63e-06	1.82e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.63e-06	1.81e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.63e-06	1.81e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.63e-06	1.81e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.62e-06	1.8e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.62e-06	1.8e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.62e-06	1.8e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.61e-06	1.79e-05	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.61e-06	1.79e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.6e-06	1.77e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.59e-06	1.77e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.59e-06	1.77e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.58e-06	1.76e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.58e-06	1.76e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.58e-06	1.75e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.56e-06	1.73e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.55e-06	1.73e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.55e-06	1.72e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.55e-06	1.72e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-06	1.72e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.54e-06	1.71e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.54e-06	1.71e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.53e-06	1.7e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.52e-06	1.69e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.52e-06	1.69e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.52e-06	1.69e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.51e-06	1.68e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	1.5e-06	1.67e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.49e-06	1.66e-05	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.49e-06	1.66e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.49e-06	1.66e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.49e-06	1.66e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.49e-06	1.66e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.49e-06	1.66e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.49e-06	1.65e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.49e-06	1.65e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.48e-06	1.65e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.48e-06	1.64e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.47e-06	1.63e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.47e-06	1.63e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.46e-06	1.63e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.46e-06	1.62e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.46e-06	1.62e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.45e-06	1.61e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.43e-06	1.59e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	1.58e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.41e-06	1.57e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.4e-06	1.56e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.4e-06	1.56e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.38e-06	1.54e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.38e-06	1.53e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.38e-06	1.53e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.38e-06	1.53e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.37e-06	1.53e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.37e-06	1.52e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.36e-06	1.51e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.36e-06	1.51e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.36e-06	1.51e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.36e-06	1.51e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.35e-06	1.5e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.34e-06	1.49e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.34e-06	1.49e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.32e-06	1.46e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.31e-06	1.46e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.29e-06	1.43e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.28e-06	1.43e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.27e-06	1.41e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.27e-06	1.41e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.27e-06	1.41e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	1.4e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.26e-06	1.4e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.26e-06	1.4e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-06	1.39e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.25e-06	1.39e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.24e-06	1.38e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.24e-06	1.38e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	1.23e-06	1.37e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.21e-06	1.34e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.2e-06	1.33e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.19e-06	1.32e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.18e-06	1.32e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.18e-06	1.32e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.18e-06	1.31e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.17e-06	1.3e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-06	1.3e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	1.3e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.15e-06	1.28e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.15e-06	1.28e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.15e-06	1.28e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.14e-06	1.27e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1.13e-06	1.26e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.1e-06	1.23e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.1e-06	1.22e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	1.19e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-06	1.18e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.06e-06	1.18e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.06e-06	1.17e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.05e-06	1.17e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.04e-06	1.16e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	1.04e-06	1.16e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.04e-06	1.16e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.03e-06	1.15e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	1.13e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.02e-06	1.13e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.01e-06	1.13e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.01e-06	1.12e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	9.86e-07	1.1e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	9.7e-07	1.08e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	9.58e-07	1.06e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	9.54e-07	1.06e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	9.52e-07	1.06e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	9.48e-07	1.05e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	9.34e-07	1.04e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	8.95e-07	9.94e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	8.88e-07	9.86e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	8.8e-07	9.78e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	8.78e-07	9.76e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	8.68e-07	9.65e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	8.62e-07	9.58e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.12e-07	9.02e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	8.01e-07	8.9e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.24e-07	6.94e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.29e-07	5.88e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.08e-07	4.53e-06	CbGpPWpGaD
